The Conjuring Trick: Private Equity and the Manufacture of Value

There is a comfortable story the private equity industry tells about itself. It buys tired, badly run companies, sharpens them up, and sells them on as fitter, more productive enterprises — value created, everyone better off. It is a flattering account, and like most flattering accounts it survives by leaving out the mechanism. Look at the mechanism and a different picture emerges: an industry whose returns depend far less on building anything than on rearranging who owns what, who owes what, and who collects the fees. The cleverness is real. It is just financial cleverness, not industrial cleverness — and the company that gets bought is, more often than the brochures admit, the party that pays for it.

The trick is in the balance sheet

Start with how a leveraged buyout actually works, because everything follows from it. A PE fund identifies a target and buys it using a modest slice of its own money and a large slice of borrowed money — commonly something like a fifth equity, four-fifths debt. The decisive sleight of hand is where that debt lands. It is not booked against the fund. It is loaded onto the acquired company itself, which in effect borrows to finance its own purchase and is then obliged to service that debt out of its own cash flow.

This single structural fact does most of the work. The sponsor has converted a company's future earnings into collateral for a loan it did not have to repay personally, and has done so while putting comparatively little of its own capital at risk. From that moment the company is running uphill: revenue that might have gone into wages, prices, stores, websites or research is instead routed to creditors. The business has not been improved. It has been re-plumbed so that money flows outward.

Where the money is actually made

Once you see the plumbing, the sources of return stop looking like value creation and start looking like accounting.

The first is fees. The sponsor charges management fees and transaction fees, and crucially extracts them regardless of how the company eventually performs. The second is the dividend recapitalisation — re-leveraging the company partway through the holding period to pay the owners a dividend, so that cash is out of the door long before any sale and irrespective of the company's later fate. The third is multiple arbitrage: buy at, say, six times earnings, sell at nine, having invented nothing and improved nothing operationally — the gain is a function of timing, market conditions, and the brute fact that larger companies command higher multiples. The fourth is leverage itself, which simply magnifies the return on an asset that was going to rise anyway. A geared bet on a rising asset is a financing decision, not an act of value creation.

None of these four channels requires the company to be worth more in any real sense. They require it to look worth more at the point of sale, and to have generated extractable cash along the way. That is the conjuring trick: a set of techniques for enriching the owner that are largely indifferent to whether the underlying enterprise is healthier or sicker.

The asymmetry, illustrated

The clearest proof that this is extraction rather than creation is what happens when a deal fails. Consider Toys "R" Us. In 2005 a consortium of Bain Capital, KKR and Vornado took it private for $6.6 billion, contributing only about $1.3 billion of their own money and financing roughly 80% with debt. The debt was then pushed onto the retailer. By the time it filed for bankruptcy in 2017 the company carried about $5 billion in debt and was spending roughly $400 million a year simply to service it.

Here is the part that ought to settle the argument. Stripped of those debt payments, the business was viable: the company filed for Chapter 11 despite reported annual operating profit of around $150 million. A retailer responsible for a fifth of American toy sales did not fail because it could not sell toys. It failed because it had been made to carry a financial burden its operations were never asked to carry before the buyout. And the asymmetry is total: 33,000 employees lost their jobs and the funds' own investors were wiped out, yet the sponsors appear to have collected $464 million in fees and interest during their ownership. The owners were paid for destroying the company. The structure did exactly what it was built to do.

"But they make companies more efficient"

The honest version of the industry's defence is worth meeting head-on, because it is not pure invention. There is academic evidence that PE-owned firms sometimes adopt better management practices and post genuine productivity gains. I will concede that freely. But three things bound that defence almost to nothing.

First, efficiency is the lesser kind of value, and PE is confined to it by design. Sustained prosperity comes from invention — pushing outward the frontier of what is possible — not from running existing operations a little tighter. PE structurally avoids invention. The model needs stable, predictable cash flows to service fixed debt; speculative, research-heavy bets are precisely what it cannot underwrite. So even at its best, the industry plays only in the cheaper seats of value creation, and never in the premium ones it likes to invoke.

Second, "efficiency" is frequently the polite word for stripping. The most rigorous evidence we have on what PE ownership does to a vulnerable business is brutal. A major NBER study of US nursing homes found that private equity ownership increased short-term patient mortality by about 10%, implying roughly 21,000 additional deaths over the study period. The mechanism was exactly the cost discipline the industry celebrates — fewer frontline nursing staff and weaker compliance with care standards — while, tellingly, spending rose by 19%, most of it billed to taxpayers. That is not a story of a sleepy firm professionalised. It is a story of value transferred out of patients and the public purse and into the deal.

Third, and decisively: even where genuine operational improvement occurs, the gains accrue to the sponsor, not to the company, its workers, or its creditors. The whole architecture — debt on the target, fees off the top, dividends pulled forward, returns geared — exists to channel any upside to the fund while leaving the downside with everyone else. The defence concedes the prosecution's case. The question was never whether a company can occasionally be improved under PE ownership. It is whether the model is built to improve companies. It is not. It is built to enrich the owner whether the company thrives or dies, and to call the result "value creation" in both cases.

The state pays for the magic

What makes this more than a private affair is that the public subsidises it twice. Interest on the acquisition debt is tax-deductible, so the Exchequer effectively underwrites the very leverage that hollows the company out. And the sponsors' reward has, for decades, enjoyed a softer tax treatment than ordinary earnings. That is finally tightening in the UK: from 6 April 2026 carried interest moves out of the capital gains regime and is taxed as trading income, at an effective rate of around 34% once the qualifying multiplier is applied — closing part, though not all, of a gap that long let performance fees be taxed more lightly than a nurse's salary.

The real indictment

The case against private equity is not that it never creates value. Occasionally it does. The case is that the industry has perfected a set of financial techniques — debt shifted onto the target, fees taken upfront, dividends pulled forward, multiples arbitraged, returns geared, the whole edifice tax-advantaged — that pay the sponsor handsomely whether or not anything of real worth is built. Value creation is optional. Value extraction is the design. And the genius of the trick is that the accounting lets you book the second as the first.

That is why "they don't invent anything" is the right instinct, even if it is not quite the right sentence. The problem is not the absence of invention. It is the presence of an apparatus that manufactures the appearance of value, banks the proceeds, and leaves the company holding the debt.